A J M van Oosterhout
Overview
Explore the profile of A J M van Oosterhout including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hoffmann R, Jonker M, Brandenburg S, de Bruin H, Ten Hacken N, van Oosterhout A, et al.
Sci Rep
. 2019 Oct;
9(1):15047.
PMID: 31636329
COPD is characterized by chronic lung inflammation and irreversible lung tissue damage. Inhaled noxious gases, including cigarette smoke, are the major risk factor for COPD. Inhaled smoke first encounters the...
2.
Post S, Heijink I, Hesse L, Koo H, Shaheen F, Fouadi M, et al.
Sci Rep
. 2018 Sep;
8(1):13275.
PMID: 30185803
The airway epithelium regulates responses to aeroallergens, acting as a physical and immunological barrier. In asthma, epithelial barrier function and the expression of adherens junction protein E-cadherin is compromised, but...
3.
Hesse L, Brouwer U, Petersen A, Gras R, Bosman L, Brimnes J, et al.
Clin Exp Allergy
. 2018 May;
48(8):1035-1049.
PMID: 29752757
Background: Both subcutaneous and sublingual allergen immunotherapy (SCIT and SLIT) have been shown to effectively suppress allergic manifestations upon allergen exposure, providing long-term relief from symptoms in allergic disorders including...
4.
Heijink I, Jonker M, de Vries M, van Oosterhout A, Telenga E, Ten Hacken N, et al.
Respir Res
. 2016 Jan;
17:2.
PMID: 26739349
Background: COPD patients have a higher risk of pneumonia when treated with fluticasone propionate (FP) than with placebo, and a lower risk with budesonide (BUD). We hypothesized that BUD and...
5.
de Vries M, Hesse L, Jonker M, van den Berge M, van Oosterhout A, Heijink I, et al.
Am J Physiol Lung Cell Mol Physiol
. 2015 Oct;
309(11):L1344-53.
PMID: 26453516
Most patients with allergic asthma are sensitized to house dust mite (HDM). The allergenicity of HDM largely depends on disruption of the integrity and proinflammatory activation of the airway epithelium....
6.
Bidad K, Nawijn M, van Oosterhout A, van der Heide S, Oude Elberink J
Cytometry B Clin Cytom
. 2014 Aug;
PMID: 25088565
No abstract available.
7.
de Vries M, Heijink I, Gras R, den Boef L, Reinders-Luinge M, Pouwels S, et al.
Am J Physiol Lung Cell Mol Physiol
. 2014 May;
307(3):L240-51.
PMID: 24816488
Exposure to cigarette smoke (CS) is the main risk factor for developing chronic obstructive pulmonary disease and can induce airway epithelial cell damage, innate immune responses, and airway inflammation. We...
8.
Robbe P, Spierenburg E, Draijer C, Brandsma C, Telenga E, van Oosterhout A, et al.
Thorax
. 2014 Feb;
69(7):630-7.
PMID: 24536057
Rationale: A low prevalence of asthma and atopy has been shown in farmers and agricultural workers. However, in these workers, a higher prevalence of respiratory symptoms has been reported, in...
9.
Bidad K, Nawijn M, van Oosterhout A, van der Heide S, Oude Elberink J
Cytometry B Clin Cytom
. 2013 Dec;
PMID: 24327387
Background: There is need for an accurate diagnostic test in mastocytosis patients with wasp venom allergy (WVA) and monitoring of these patients during immunotherapy (IT). In this study, we aimed...
10.
Pouwels S, Heijink I, Ten Hacken N, Vandenabeele P, Krysko D, Nawijn M, et al.
Mucosal Immunol
. 2013 Oct;
7(2):215-26.
PMID: 24150257
Chronic obstructive pulmonary disease (COPD), a progressive lung disease characterized by sustained neutrophilic airway inflammation, is caused by chronic exposure to noxious stimuli, e.g., cigarette smoke. This chronic exposure can...